Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-30 @ 12:12 AM
Study NCT ID:
NCT01231503
Status:
COMPLETED
Last Update Posted:
2018-08-15
First Post:
2010-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2014-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-14
First Submit QC Date:
None
Study First Post Date:
2010-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-04
Results First Submit QC Date:
None
Results First Post Date:
2015-05-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-17
Last Update Post Date:
2018-08-15
Last Update Post Date Type:
ACTUAL